Sangamo BioSciences research collaborators awarded grant from California Institute for Regenerative Medicine to develop zinc finger nuclease-based stem cell therapy for HIV/AIDS.

Sangamo BioSciences Inc announced that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 M Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells. The four year grant supports an innovative research project conducted by a multidisciplinary team of investigators led by John Zaia, MD the Aaron D and Edith Miller Chair in Gene Therapy and chair of virology, City of Hope. The grant application entitled, Zinc Finger Nuclease-Based Stem Cell Therapy for AIDS won the highest score of all grants CIRM received in this 1st round of Disease Team Research …